Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $3.94B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.04B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| EWTX | IONS | |
|---|---|---|
Market Cap | $3.94B | $7.04B |
Volume | 810,104 | 2,977,440 |
Sector | Health | Health |
52-Week High | $48.35 | $86.50 |
52-Week Low | $14.89 | $42.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $6.60B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
